Larimar Therapeutics, Inc.

LRMR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$33,218$26,749$26,825$70,097
Short-Term Investments$150,236$60,041$91,603$0
Receivables$1,054$0$0$208
Inventory$0$0$0$0
Other Curr. Assets$10,796$3,385$2,311$1,899
Total Curr. Assets$195,304$90,175$120,739$72,204
Property Plant & Equip (Net)$3,719$3,762$3,689$4,455
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$1,339$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,202$659$1,977$2,008
Total NC Assets$4,921$5,760$5,666$6,463
Other Assets$0$0$0$0
Total Assets$200,225$95,935$126,405$78,667
Liabilities
Payables$2,424$1,283$1,686$1,660
Short-Term Debt$1,060$837$611$594
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$20,872$7,386$8,408$6,592
Total Curr. Liab.$24,356$9,506$10,705$8,846
LT Debt$4,057$4,709$4,797$5,408
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$4,057$4,709$4,797$5,408
Other Liabilities$0$0$0$0
Cap. Leases$5,117$5,546$5,408$6,002
Total Liabilities$28,413$14,215$15,502$14,254
Equity
Pref Stock$0$0$0$0
Common Stock$64$43$43$18
Retained Earnings-$269,158-$188,554-$151,605-$116,250
AOCI$148$81-$31$0
Other Equity$440,758$270,150$262,496$180,645
Total Equity$171,812$81,720$110,903$64,413
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$200,225$95,935$126,405$78,667
Net Debt-$28,101-$21,203-$21,417-$64,095
Larimar Therapeutics, Inc. (LRMR) Financial Statements & Key Stats | AlphaPilot